These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 21493890

  • 1. Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
    Hu X, Atzler D, Xu X, Zhang P, Guo H, Lu Z, Fassett J, Schwedhelm E, Böger RH, Bache RJ, Chen Y.
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1540-6. PubMed ID: 21493890
    [Abstract] [Full Text] [Related]

  • 2. Dimethylarginine dimethylaminohydrolase 1 modulates endothelial cell growth through nitric oxide and Akt.
    Zhang P, Hu X, Xu X, Chen Y, Bache RJ.
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):890-7. PubMed ID: 21212404
    [Abstract] [Full Text] [Related]

  • 3. DDAH says NO to ADMA.
    Cooke JP, Ghebremariam YT.
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1462-4. PubMed ID: 21677286
    [No Abstract] [Full Text] [Related]

  • 4. Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis.
    Lange C, Mowat F, Sayed H, Mehad M, Duluc L, Piper S, Luhmann U, Nandi M, Kelly P, Smith A, Ali R, Leiper J, Bainbridge J.
    Exp Eye Res; 2016 Jun; 147():148-155. PubMed ID: 27181226
    [Abstract] [Full Text] [Related]

  • 5. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
    Reddy KRK, Dasari C, Duscharla D, Supriya B, Ram NS, Surekha MV, Kumar JM, Ummanni R.
    Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732
    [Abstract] [Full Text] [Related]

  • 6. Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease.
    Liu X, Xu X, Shang R, Chen Y.
    Nitric Oxide; 2018 Aug 01; 78():113-120. PubMed ID: 29928990
    [Abstract] [Full Text] [Related]

  • 7. Dimethylarginine dimethylaminohydrolase 1 regulates nerve growth factor-promoted differentiation of PC12 cells in a nitric oxide-dependent but asymmetric dimethylargenine-independent manner.
    Wang S, Hu CP, Yuan Q, Zhang WF, Zhou Z, Nie SD, Jiang JL, Li YJ.
    J Neurosci Res; 2012 Jun 01; 90(6):1209-17. PubMed ID: 22488726
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine.
    Hu X, Xu X, Zhu G, Atzler D, Kimoto M, Chen J, Schwedhelm E, Lüneburg N, Böger RH, Zhang P, Chen Y.
    Circulation; 2009 Dec 01; 120(22):2222-9. PubMed ID: 19917889
    [Abstract] [Full Text] [Related]

  • 9. Disruption of methylarginine metabolism impairs vascular homeostasis.
    Leiper J, Nandi M, Torondel B, Murray-Rust J, Malaki M, O'Hara B, Rossiter S, Anthony S, Madhani M, Selwood D, Smith C, Wojciak-Stothard B, Rudiger A, Stidwill R, McDonald NQ, Vallance P.
    Nat Med; 2007 Feb 01; 13(2):198-203. PubMed ID: 17273169
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction.
    Xu X, Zhang P, Kwak D, Fassett J, Yue W, Atzler D, Hu X, Liu X, Wang H, Lu Z, Guo H, Schwedhelm E, Böger RH, Chen P, Chen Y.
    Basic Res Cardiol; 2017 Aug 17; 112(5):55. PubMed ID: 28819685
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
    Dayal S, Rodionov RN, Arning E, Bottiglieri T, Kimoto M, Murry DJ, Cooke JP, Faraci FM, Lentz SR.
    Am J Physiol Heart Circ Physiol; 2008 Aug 17; 295(2):H816-25. PubMed ID: 18567702
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
    Sakurada M, Shichiri M, Imamura M, Azuma H, Hirata Y.
    Hypertension; 2008 Nov 17; 52(5):903-9. PubMed ID: 18824664
    [Abstract] [Full Text] [Related]

  • 18. Endothelial Dimethylarginine Dimethylaminohydrolase 1 Is an Important Regulator of Angiogenesis but Does Not Regulate Vascular Reactivity or Hemodynamic Homeostasis.
    Dowsett L, Piper S, Slaviero A, Dufton N, Wang Z, Boruc O, Delahaye M, Colman L, Kalk E, Tomlinson J, Birdsey G, Randi AM, Leiper J.
    Circulation; 2015 Jun 23; 131(25):2217-25. PubMed ID: 25910799
    [Abstract] [Full Text] [Related]

  • 19. Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2.
    Ivashchenko CY, Bradley BT, Ao Z, Leiper J, Vallance P, Johns DG.
    Am J Physiol Heart Circ Physiol; 2010 Jan 23; 298(1):H251-8. PubMed ID: 19915177
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.